India’s Medtech Sector Targets Rapid Growth in Exports to the United Kingdom by 2030

India’s medical technology sector has announced an ambitious goal to triple the value of its exports to the United Kingdom by 2030. This signals a deepening partnership between both countries and reflects India’s intention to become a leading global supplier of high quality and affordable medical devices.

Current exports stand at around ninety six million pounds. Senior industry leaders now aim to increase this to a range of two hundred and fifty million pounds to three hundred million pounds. This ambition was reinforced during a recent roundtable in the United Kingdom Parliament where representatives from both countries discussed new opportunities for investment, market entry and regulatory cooperation.

The United Kingdom is already a significant destination for Indian medical devices, although it currently represents only a small segment of India’s total medtech exports. Achieving the new target would greatly expand India’s presence in the United Kingdom healthcare market and provide the National Health Service with wider access to consumables, diagnostic tools, monitoring systems and digital health technologies.

India’s export ambition is backed by a national strategy to position the country as a world leading medical device manufacturing hub by 2030. Targeted government incentives, expanded investment and the development of new innovation clusters support this long term vision.

New United Kingdom and India Trade Agreement Creates Lower Costs and Simpler Market Access

A major driver behind the expected growth is the new United Kingdom and India trade deal which introduces several measures that directly benefit medical device companies in both countries.

• Indian medical device exports to the United Kingdom will now carry zero tariffs, a significant reduction from the duties applied in the current system.
• A mutual recognition agreement framework will simplify the market access process by allowing certain Indian certified devices to enter the United Kingdom market with fewer regulatory hurdles.
• Companies will benefit from simplified regulatory procedures, making it easier and less costly to trade medical devices between both countries.
• The United Kingdom will also enjoy reduced tariffs and clearer regulatory pathways for its medical device exports into India, creating new opportunities within India’s rapidly expanding healthcare market.

These changes are expected to accelerate trade, reduce compliance burdens and increase commercial confidence for manufacturers on both sides.

Growing Market Opportunity for Indian Companies as the United Kingdom Reassesses Supply Chains

Market analysts note that the United Kingdom is actively reviewing its healthcare supply chains to build resilience and diversify its supplier base. India’s strong manufacturing capabilities, competitive pricing and expanding innovation landscape make it a timely and attractive option for United Kingdom buyers.

If India achieves its 2030 export target, it will mark one of the most significant shifts in medtech trade between the two nations. The expansion could also support increased collaboration in research, shared manufacturing ventures and digital health development.

Why EBME Expo 2026 Offers a Prime Route into the United Kingdom Market

The combination of India’s export ambition and the new trade agreement creates a powerful opportunity for Indian manufacturers to strengthen their presence in the United Kingdom. Exhibiting at EBME Expo 2026 offers a direct commercial advantage because the event brings together:

• Importers and distributors seeking new international suppliers
• NHS Supply Chain professionals who influence national purchasing decisions
• Hospital procurement teams with substantial buying power
• Clinical engineers, technical managers and medical device specialists who evaluate and recommend technologies for hospital use
• Decision makers from public and private healthcare organisations

This audience represents the full buying chain for medical devices in the United Kingdom, giving international exhibitors an unmatched opportunity to present their technologies to the professionals who make purchasing decisions.

Indian manufacturers are especially well positioned to benefit. With zero tariffs, simpler certification pathways and rising demand for value driven solutions, the United Kingdom market is more open to Indian medtech than ever before. EBME Expo 2026 provides a strategic platform to build relationships, strengthen credibility and establish a larger footprint in one of the world’s most respected healthcare systems.

As India works toward its goal of reaching up to three hundred million pounds in medtech exports to the United Kingdom, EBME Expo 2026 stands out as a vital gateway for companies seeking growth, visibility and long term commercial partnerships.

Book a stand